SUV420H1 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 7.553600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
9.344200E-01
Normal-vs-Stage2
7.762000E-01
Normal-vs-Stage3
4.314400E-01
Normal-vs-Stage4
2.556000E-01
Stage1-vs-Stage2
7.778200E-01
Stage1-vs-Stage3
3.901400E-01
Stage1-vs-Stage4
1.596430E-01
Stage2-vs-Stage3
4.113600E-01
Stage2-vs-Stage4
4.748200E-02
Stage3-vs-Stage4
8.737500E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
7.683600E-01
Normal-vs-AfricanAmerican
9.779400E-01
Normal-vs-Asian
3.607200E-01
Caucasian-vs-AfricanAmerican
6.492600E-01
Caucasian-vs-Asian
2.129200E-01
AfricanAmerican-vs-Asian
2.503600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
7.783200E-01
Normal-vs-Female
7.430200E-01
Male-vs-Female
9.364800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
2.869800E-01
Normal-vs-Age(41-60Yrs)
9.073800E-01
Normal-vs-Age(61-80Yrs)
6.440000E-01
Normal-vs-Age(81-100Yrs)
6.607800E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
2.409200E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
6.325000E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
6.373000E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
3.895600E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
2.534600E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
9.927800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
3.682000E-01
Normal-vs-Daily Drinker
5.649000E-01
Normal-vs-Weekly Drinker
6.794200E-01
Normal-vs-Occasional Drinker
6.671400E-01
Normal-vs-Social Drinker
9.463000E-01
Non Drinker-vs-Daily Drinker
7.067600E-01
Non Drinker-vs-Weekly Drinker
5.635200E-01
Non Drinker-vs-Occasional Drinker
1.016120E-02
Non Drinker-vs-Social Drinker
1.096810E-01
Daily Drinker-vs-Weekly Drinker
8.316600E-01
Daily Drinker-vs-Occasional Drinker
6.040300E-02
Daily Drinker-vs-Social Drinker
3.042600E-01
Weekly Drinker-vs-Occasional Drinker
1.516610E-01
Weekly Drinker-vs-Social Drinker
4.850000E-01
Occasional Drinker-vs-Social Drinker
3.607200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
4.370500E-02
Normal-vs-Grade 2
3.423200E-03
Normal-vs-Grade 3
5.964200E-03
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
6.127700E-02
Grade 1-vs-Grade 3
1.471850E-02
Grade 1-vs-Grade 4
4.370500E-02
Grade 2-vs-Grade 3
1.704780E-01
Grade 2-vs-Grade 4
3.423200E-03
Grade 3-vs-Grade 4
5.964200E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
5.530200E-01
Normal-vs-NonDiabetic
6.977200E-01
Diabetic-vs-NonDiabetic
3.947200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
8.445600E-01
Normal-vs-NoPancreatitis
6.246800E-01
Pancreatitis-vs-NoPancreatitis
2.071000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
8.534000E-01
Normal-vs-N1
7.443600E-01
N0-vs-N1
6.629400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
5.372400E-01
Normal-vs-TP53-NonMutant
7.799200E-01
TP53-Mutant-vs-TP53-NonMutant
3.104600E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
